{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:25:37Z","timestamp":1780511137106,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bulcan.2021.04.010","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T08:50:23Z","timestamp":1628758223000},"page":"981-987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Survival and prognosis of lung large cell neuroendocrine carcinoma"],"prefix":"10.1016","volume":"108","author":[{"given":"Hui","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuji","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2573-1080","authenticated-orcid":false,"given":"Yahua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2021.04.010_bib0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtho.2016.11.2222","article-title":"Neuroendocrine tumors of the lung: current challenges and advances in the diagnosis and management of well-differentiated disease","volume":"12","author":"Hendifar","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0110","first-page":"60","article-title":"Of WHO classification of tumours of the lung, published in 2015","volume":"23","author":"Chen","year":"2016","journal-title":"Chin J Cancer Prev Treat"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0115","first-page":"9","article-title":"Pathologic consensus of pulmonary neuroendocrine tumors","volume":"46","author":"Pathologic Consensus of Pulmonary Neuroendocrine Tumors Group","year":"2017","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0120","series-title":"WHO classification of tumours of the lung, pleura, thymus and heart","year":"2015"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0125","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jtho.2016.03.025","article-title":"The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer","volume":"11","author":"Travis","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.arbres.2014.02.004","article-title":"Diagnosis and treatment of neuroendocrine lung tumors","volume":"50","author":"S\u00e1nchez de Cos Escu\u00edn","year":"2014","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0135","first-page":"1299","article-title":"Clinicopathological analysis of large cell neuroendocrine carcinoma","volume":"17","author":"Gao","year":"2012","journal-title":"J Clin Pulm Med"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2008.05.007","article-title":"The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study","volume":"63","author":"Dediu","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0145","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/1759-7714.12993","article-title":"Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: a large population-based analysis","volume":"10","author":"Yang","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0150","first-page":"848","article-title":"Clinical analysis of 31 cases of large cell neuroendocrine carcinomas","volume":"25","author":"Fang","year":"2015","journal-title":"Zhejiang J Integr Trad Chin West Med"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.lungcan.2012.04.009","article-title":"Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?","volume":"77","author":"Sun","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0160","first-page":"1319","article-title":"Clinical analysis of 37 cases of large cell neuroendocrine carcinoma (LCNEC)","volume":"38","author":"Shen","year":"2018","journal-title":"Basic Clin Med"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0165","first-page":"98","article-title":"Surgical treatment and prognosis factor for large cell neuroendocrine carcinoma","volume":"7","author":"Chen","year":"2016","journal-title":"Med J Peking Union Med Coll Hosp"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ejcts\/ezs174","article-title":"Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience","volume":"43","author":"Fournel","year":"2013","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11748-014-0379-9","article-title":"Treatment options for patients with large cell neuroendocrine carcinoma of the lung","volume":"62","author":"Iyoda","year":"2014","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0180","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00268-017-3908-8","article-title":"Outcomes of curative-intent surgery and adjuvant treatment for pulmonary large cell neuroendocrine carcinoma","volume":"41","author":"Kim","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0185","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00128-2016","article-title":"Evaluation of the efficacy of cisplatin-etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC","volume":"3","author":"Prelaj","year":"2017","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0190","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.cllc.2019.07.011","article-title":"Large cell neuroendocrine carcinoma of the lung: a population-based study","volume":"21","author":"Kinslow","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0195","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.lungcan.2011.08.012","article-title":"Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens","volume":"75","author":"Shimada","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bulcan.2021.04.010_bib0200","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/cam4.2188","article-title":"The demographic and treatment options for patients with large cell neuroendocrine carcinoma of the lung","volume":"8","author":"Gu","year":"2019","journal-title":"Cancer Med"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121002083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121002083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:34:31Z","timestamp":1757792071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455121002083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0007455121002083"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.04.010","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival and prognosis of lung large cell neuroendocrine carcinoma","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer.","name":"copyright","label":"Copyright"}]}}